Alpine Partners VI »

Taysha Gene Therapies shares owned by Alpine Partners VI

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Alpine Partners VI from 13F filings

Historical chart of Alpine Partners VI investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Alpine Partners VI consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Alpine Partners VI

Quarter filed Position value Share count Share price at filing
2024-06-30 $339k 152k 2.24

More positions owned by Alpine Partners VI

Immunovant (IMVT)
Cornerstone Strategic Value (CLM)
Robinhood Mkts Com Cl A (HOOD)
Cornerstone Total Rtrn Fd In (CRF)
Archer Aviation Com Cl A (ACHR)
Blackrock Muni Intermediate Drtn Fnd (MUI)
Burlington Stores Note 2.250% 4/1
Redfin Corp Note 0.500% 4/0
Blackrock Capital Allocation Trust (BCAT)
Rivian Automotive Note 4.625% 3/1
Stericycle (SRCL)
Blackrock Esg Cap Allc Term Shs Ben Int (ECAT)
Pagaya Technologies Cl A New (PGY)
Jazz Investments I Note 2.000% 6/1
ON Semiconductor (ON)

View all positions for Alpine Partners VI

Top funds holding Taysha Gene Therapies

FMR
venBio Select Advisor
Rtw Investments
BlackRock
RA Capital Management
VR Adviser
Vanguard Group
Siren
Octagon Capital Advisors
Baker Bros. Advisors
Tybourne Capital Management
Geode Capital Management
State Street Corporation
Polar Capital Holdings
Jpmorgan Chase & Co

View all funds holding Taysha Gene Therapies